17 Large Cap Stocks Just Made New 52-Week Highs
A list of market leaders shows a clear industry pattern, but one giant’s valuation stands apart.
Merck (MRK), a company with a market value of about $335.8 billion, just hit a new high. It leads a list of 17 Large Cap stocks reaching their strongest price of the past year on Friday.
The list is heavily concentrated in the Financials sector, with 6 names from the Diversified Banks industry and 2 from Asset Management & Custody Banks. But the presence of Merck raises a central question: what does it mean when a list of leaders contains both steady banks and a pharma giant trading at 105.7 times trailing earnings? Here are the names.
The Ten Largest At New Highs
- The 52-Week-High List: 13 S&P 500 Names On Tuesday
- 25 Small Cap Stocks Just Made New 52-Week Highs
- S&P 500 Movers | Winners: TRGP, PODD, ULTA | Losers: COHR, LITE, STX
- Where The Selling Ran Deepest: 5 S&P 500 Stocks At 52-Week Lows
- Mid Cap Stocks At 52-Week Highs: Tuesday’s Full List
- 23 Stocks Hit 52-Week Lows On Tuesday
The table below shows the 10 largest of the 17 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| MRK | $335.8 Bil | 0.2% | 5.6% | 6.4% | 69.7% |
| RY | $301.7 Bil | 0.7% | 2.6% | 0.8% | 63.8% |
| SCHW | $194.0 Bil | 1.2% | 3.5% | 8.4% | 17.7% |
| BMO | $131.6 Bil | 0.9% | 2.3% | 2.5% | 67.5% |
| CM | $113.5 Bil | 1.1% | 4.2% | 2.5% | 74.2% |
| BNY | $112.8 Bil | 0.6% | 3.6% | 1.9% | 63.0% |
| BNS | $112.6 Bil | 1.0% | 3.0% | 2.1% | 68.7% |
| PNC | $104.1 Bil | 0.7% | 1.7% | 1.5% | 37.2% |
| USB | $101.7 Bil | 0.4% | 2.3% | 2.2% | 46.0% |
| PSX | $93.9 Bil | 0.4% | 14.6% | 16.0% | 97.1% |
What does a 105.7 P/E ratio tell us at a 52-week high?
Merck’s valuation stands out sharply. The company’s revenue grew 4.6% over the last twelve months and its operating margin is 10.5%. Yet its stock trades at 105.7 times trailing earnings.
Contrast that with another name on the list, Charles Schwab (SCHW). Its revenue grew 20.3% over the same period, and it trades at 19.1 times trailing earnings. Or consider Royal Bank of Canada (RY), with revenue growth of 11.9% and a multiple of 13.6. The market is pricing these new highs very differently.
Is a new high a signal to buy or a warning?
A 52-week-high list is a map of what is working. Strength often persists. But a high is a price, not a verdict on a business’s intrinsic value.
The disciplined move is to treat this list as a starting point for work, not an answer. The key question is always whether the business fundamentals can earn the stock’s new level.
A new high tells you what the market already believes. The harder question is which of these runs management itself is underwriting. Our Guidance Momentum screen tracks exactly that: stocks where the company raised its own forward numbers.
One more pattern worth noticing: 10 of the 17 names are Financials stocks. When a whole group is making new highs together, a financials ETF like XLF is one way to own the group’s strength without betting on which single name leads it from here.
Chasing Highs Is A Reflex. Owning Strength Is A System
A 52-week-high list is seductive: everything on it has been going right. But buying a stock because it is at its high is buying a price, and prices revert; what persists is the quality underneath the run.
The Trefis High Quality (HQ) Portfolio is built to own that quality before and after it makes headlines: roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Admire the list; own the system.